Bioelectronics Corp (BIEL)

[Probity]

I agree with OEM as a CONCEPT.

But the reason given for the past “deals” that fell through (at least on this forum), with CVS and others was that the margin of profit would have terrible for BIEL.

If so, we did not take into account the value of being on the shelves of a company like CVS found on every corner, in terms of the future margin of profits we could have had in future renegotiations. A scaled-up initial agreement to review all aspects of the deal and redo margins when certain milestones are reached could have been worded.

The more we sell, the more power we have.

Who doesn’t want a potentially DISRUPTIVE TECHNOLOGY on their shelves?

So, while OEM is a great idea, it is not practical to expect that the partner is going to take on all of the responsibilities listed and BIEL will gain a BETTER margin of profit we could have had with CVS or others right now.

The partner will be sure to manage the cost of advertising, packaging, sales team, etc. somewhere in the contract in BIEL's profit margin take.

We could have built massive SALES over time by virtue of SHELF PRESENCE and all that brings down the road in the turned down deals.

There is no free lunch. We are no Intel. We could be after a while. We don't have that OEM power. Maybe later?

We’re not in the catbird seat imo. We need OEM more than they need us. We come from a weak negotiation position in terms of SALES HISTORY to offer as proof to a prospective partner that we are indeed………..a disruptive technology.

For them, SALES HISTORY takes precedence over the FDA approvals we have when sitting at the negotiation table and taking about profit margins.

All IMO.